Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib.

McGrath AC, Sandhu G, Walpole E, McCaffrey E, Hollingworth SA.

Anticancer Drugs. 2018 Sep;29(8):786-790. doi: 10.1097/CAD.0000000000000640.

PMID:
30110016
2.

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use.

Pache DM, Hollingworth SA, van Driel ML, McGuire TM.

Res Social Adm Pharm. 2018 Jun 18. pii: S1551-7411(17)30983-X. doi: 10.1016/j.sapharm.2018.06.012. [Epub ahead of print]

PMID:
29935855
3.

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Adewumi AD, Staatz CE, Hollingworth SA, Connor JP, Alati R.

Drug Saf. 2018 Nov;41(11):1023-1033. doi: 10.1007/s40264-018-0687-6. Review.

PMID:
29796831
4.

Correction to: Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.

Hollingworth SA, Winckel K, Saiepour N, Wheeler AJ, Myles N, Siskind D.

Psychopharmacology (Berl). 2018 Jul;235(7):2193. doi: 10.1007/s00213-018-4909-5.

PMID:
29704218
5.

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.

Hollingworth SA, Winckel K, Saiepour N, Wheeler AJ, Myles N, Siskind D.

Psychopharmacology (Berl). 2018 Jul;235(7):1915-1921. doi: 10.1007/s00213-018-4881-0. Epub 2018 Mar 27. Erratum in: Psychopharmacology (Berl). 2018 Apr 23;:.

PMID:
29589067
6.

More needs to be spent on hepatitis C treatment, not less.

Clark PJ, Muranushi C, Hollingworth SA.

Intern Med J. 2018 Mar;48(3):364-366. doi: 10.1111/imj.13718. No abstract available.

PMID:
29512321
7.

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose.

Adewumi AD, Hollingworth SA, Maravilla JC, Connor JP, Alati R.

CNS Drugs. 2018 Feb;32(2):101-116. doi: 10.1007/s40263-018-0499-3. Review.

PMID:
29498021
8.

Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australia.

Staatz CE, Martin NS, Kong DP, Hollingworth SA.

Dig Liver Dis. 2018 Mar;50(3):314-317. doi: 10.1016/j.dld.2017.12.016. Epub 2017 Dec 24. No abstract available.

PMID:
29311026
9.

Small Ca2+ releases enable hour-long high-frequency contractions in midshipman swimbladder muscle.

Nelson FE, Hollingworth S, Marx JO, Baylor SM, Rome LC.

J Gen Physiol. 2018 Jan 2;150(1):127-143. doi: 10.1085/jgp.201711760. Epub 2017 Dec 19.

10.

A perspective on Na and K channel inactivation.

Armstrong CM, Hollingworth S.

J Gen Physiol. 2018 Jan 2;150(1):7-18. doi: 10.1085/jgp.201711835. Epub 2017 Dec 12. Review.

11.

Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX).

Siskind DJ, Russell AW, Gamble C, Winckel K, Mayfield K, Hollingworth S, Hickman I, Siskind V, Kisely S.

Diabetes Obes Metab. 2018 Apr;20(4):1050-1055. doi: 10.1111/dom.13167. Epub 2017 Dec 19.

PMID:
29194917
12.

Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers.

Khanal S, Veerman L, Nissen L, Hollingworth S.

J Clin Diagn Res. 2017 Jun;11(6):LC01-LC05. doi: 10.7860/JCDR/2017/25021.9970. Epub 2017 Jun 1.

13.

The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies.

Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA.

Menopause. 2018 Jan;25(1):109-120. doi: 10.1097/GME.0000000000000949. Review.

PMID:
28719420
14.

Opioid analgesic use in Australia and The Netherlands: a cross-country comparison.

Wagemaakers FN, Hollingworth SA, Kreijkamp-Kaspers S, Tee EHL, Leendertse AJ, van Driel ML.

Int J Clin Pharm. 2017 Aug;39(4):874-880. doi: 10.1007/s11096-017-0492-9. Epub 2017 Jun 12.

PMID:
28608330
15.

Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.

Sharkey MM, McKavanagh D, Walpole E, Mollee P, Hollingworth SA.

Int J Clin Pharm. 2017 Aug;39(4):836-843. doi: 10.1007/s11096-017-0480-0. Epub 2017 Jun 1.

PMID:
28573439
16.

International trends in clozapine use: a study in 17 countries.

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fusté A, Furu K, Garuoliené K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Siskind D, Skurtveit S, Verdoux H, Wang LJ, Zara Yahni C, Zoëga H, Taylor D.

Acta Psychiatr Scand. 2017 Jul;136(1):37-51. doi: 10.1111/acps.12742. Epub 2017 May 14.

PMID:
28502099
17.

Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations.

Hollingworth SA, Donald M, Zhang J, Vaikuntam BP, Russell A, Jackson C.

Prim Care Diabetes. 2017 Aug;11(4):344-347. doi: 10.1016/j.pcd.2017.03.009. Epub 2017 Apr 23.

PMID:
28442341
18.

Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.

Donges E, Staatz CE, Benham H, Kubler P, Hollingworth SA.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):907-912. Epub 2017 Apr 18.

PMID:
28421991
19.

Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012.

Hollingworth SA, Chan R, Pham J, Shi S, Ford PJ.

Community Dent Oral Epidemiol. 2017 Aug;45(4):303-309. doi: 10.1111/cdoe.12291. Epub 2017 Mar 2.

PMID:
28251672
20.

The impact of clozapine on hospital use: a systematic review and meta-analysis.

Land R, Siskind D, McArdle P, Kisely S, Winckel K, Hollingworth SA.

Acta Psychiatr Scand. 2017 Apr;135(4):296-309. doi: 10.1111/acps.12700. Epub 2017 Feb 3. Review.

PMID:
28155220
21.

Triptan use in Australia 1997-2015: A pharmacoepidemiological study.

Eyre BLKD, Eadie MJ, van Driel ML, Ross-Lee L, Hollingworth SA.

Acta Neurol Scand. 2017 Aug;136(2):155-159. doi: 10.1111/ane.12727. Epub 2017 Jan 16.

PMID:
28093722
22.

Under-reporting of socio-economic status in randomized control trials of biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.

Chiu H, Hollingworth S, Van Driel M, Magin P, Benham H.

Rheumatology (Oxford). 2017 Apr 1;56(4):660-661. doi: 10.1093/rheumatology/kew460. No abstract available.

PMID:
28039418
23.

Ezetimibe: Use, costs, and adverse events in Australia.

Hollingworth SA, Ostino R, David MC, Martin JH, Tett SE.

Cardiovasc Ther. 2017 Feb;35(1):40-46. doi: 10.1111/1755-5922.12236.

PMID:
27860332
24.

Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia.

Hollingworth SA, McGuire TM, Pache D, Eadie MJ.

Drugs Real World Outcomes. 2015 Sep;2(3):199-203.

25.

Case conference primary-secondary care planning at end of life can reduce the cost of hospitalisations.

Hollingworth S, Zhang J, Vaikuntam BP, Jackson C, Mitchell G.

BMC Palliat Care. 2016 Sep 23;15(1):84.

26.

Forecasting the quantity and cost of medicines to treat non-communicable diseases in low- and middle-income countries: Applying knowledge on medicine use from developed countries.

Khanal S, Veerman L, Nissen L, Hollingworth S.

Res Social Adm Pharm. 2017 Jan - Feb;13(1):257-258. doi: 10.1016/j.sapharm.2016.07.009. Epub 2016 Aug 10. No abstract available.

PMID:
27591096
27.

Off-label use of tumour necrosis factor-alpha inhibitors and anakinra at an Australian tertiary hospital.

Linger MW, van Driel ML, Hollingworth SA, Martin JH.

Intern Med J. 2016 Dec;46(12):1386-1391. doi: 10.1111/imj.13247.

PMID:
27572659
28.

Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.

Chapman SJ, McKavanagh D, Burge ME, McPherson I, Walpole E, Hollingworth SA.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e253-e261. doi: 10.1111/ajco.12518. Epub 2016 Jul 20.

PMID:
27435535
29.

Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease.

Peeters G, Tett SE, Hollingworth SA, Gnjidic D, Hilmer SN, Dobson AJ, Hubbard RE.

J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):259-265. doi: 10.1093/gerona/glw111. Epub 2016 Jul 6.

PMID:
27384327
30.

A Review of Medication Use as an Indicator of Human Health Impact in Environmentally Stressed Areas.

Hollingworth SA, Kim DD, Jagals P.

Ann Glob Health. 2016 Jan-Feb;82(1):111-8. doi: 10.1016/j.aogh.2016.01.010. Review.

31.

'Repeat' prescriptions and antibiotic resistance: findings from Australian community pharmacy.

Fredericks I, Hollingworth S, Pudmenzky A, Rossato L, Kairuz T.

Int J Pharm Pract. 2017 Feb;25(1):50-58. doi: 10.1111/ijpp.12273. Epub 2016 Jun 13.

PMID:
27293019
32.

Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study.

Kay M, Wijayanayaka S, Cook H, Hollingworth S.

Br J Gen Pract. 2016 Jun;66(647):e397-409. doi: 10.3399/bjgp16X685249. Epub 2016 May 9.

33.

Prescribing patterns of dental practitioners in Australia from 2001 to 2012. Antimicrobials.

Ford PJ, Saladine C, Zhang K, Hollingworth SA.

Aust Dent J. 2017 Mar;62(1):52-57. doi: 10.1111/adj.12427. Epub 2016 Dec 23.

PMID:
27121371
34.

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.

Mayfield K, Siskind D, Winckel K, Russell AW, Kisely S, Smith G, Hollingworth S.

J Psychopharmacol. 2016 Mar;30(3):227-36. doi: 10.1177/0269881115625496. Epub 2016 Jan 22. Review.

PMID:
26801056
35.

Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal.

Khanal S, Nissen L, Veerman L, Hollingworth S.

Res Social Adm Pharm. 2016 Jul-Aug;12(4):655-9. doi: 10.1016/j.sapharm.2015.09.005. Epub 2015 Sep 28.

PMID:
26481826
36.

Weak Satiety Responsiveness Is a Reliable Trait Associated with Hedonic Risk Factors for Overeating among Women.

Dalton M, Hollingworth S, Blundell J, Finlayson G.

Nutrients. 2015 Sep 4;7(9):7421-36. doi: 10.3390/nu7095345.

37.

Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy.

Fredericks I, Hollingworth S, Pudmenzky A, Rossato L, Syed S, Kairuz T.

Int J Clin Pharm. 2015 Dec;37(6):1213-21. doi: 10.1007/s11096-015-0188-y. Epub 2015 Sep 21.

PMID:
26391787
38.

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial.

Mayfield K, Siskind D, Winckel K, Hollingworth S, Kisely S, Russell AW.

BJPsych Open. 2015 Aug 20;1(1):67-73. eCollection 2015 Jun.

39.

Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal.

Khanal S, Veerman L, Hollingworth S, Nissen L.

Perspect Public Health. 2015 Jul;135(4):177-8. doi: 10.1177/1757913915586654. No abstract available.

PMID:
26148895
40.

Clozapine in the community: Improved access or risky free-for-all?

Winckel K, Siskind D, Hollingworth S, Robinson G, Mitchell S, Varghese D, Smith L, Wheeler AJ.

Aust N Z J Psychiatry. 2015 Oct;49(10):863-5. doi: 10.1177/0004867415592957. Epub 2015 Jun 22. No abstract available.

PMID:
26101397
41.

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004-2013.

Forrester T, Siskind D, Winckel K, Wheeler A, Hollingworth S.

Pharmacopsychiatry. 2015 Jul;48(4-5):164-9. doi: 10.1055/s-0035-1554713. Epub 2015 Jun 19.

PMID:
26091280
42.

Opioid analgesic prescribing in Australia: a focus on gender and age.

Hollingworth SA, Gray PD, Hall WD, Najman JM.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):628-36. doi: 10.1002/pds.3767. Epub 2015 Apr 1.

PMID:
25845470
43.

Structural and functional properties of ryanodine receptor type 3 in zebrafish tail muscle.

Perni S, Marsden KC, Escobar M, Hollingworth S, Baylor SM, Franzini-Armstrong C.

J Gen Physiol. 2015 Mar;145(3):253. doi: 10.1085/jgp.20141130302112015c. No abstract available.

44.

Structural and functional properties of ryanodine receptor type 3 in zebrafish tail muscle.

Perni S, Marsden KC, Escobar M, Hollingworth S, Baylor SM, Franzini-Armstrong C.

J Gen Physiol. 2015 Mar;145(3):173-84. doi: 10.1085/jgp.201411303. Epub 2015 Feb 9. Erratum in: J Gen Physiol. 2015 Mar;145(3):253.

45.

Clozapine-induced myocarditis: separating the wheat from the chaff.

Winckel K, Siskind D, Hollingworth S, Wheeler A.

Aust N Z J Psychiatry. 2015 Feb;49(2):188. doi: 10.1177/0004867414554269. Epub 2014 Oct 8. No abstract available.

PMID:
25296630
46.

Multiple sclerosis disease modifying medicine utilisation in Australia.

Hollingworth S, Walker K, Page A, Eadie M.

J Clin Neurosci. 2014 Dec;21(12):2083-7. doi: 10.1016/j.jocn.2014.05.034. Epub 2014 Sep 5. Review.

PMID:
25194821
47.

Effects of decentralisation and health system reform on health workforce and quality-of-care in Indonesia, 1993-2007.

Diana A, Hollingworth SA, Marks GC.

Int J Health Plann Manage. 2015 Jan-Mar;30(1):E16-30. doi: 10.1002/hpm.2255. Epub 2014 May 14.

PMID:
24825032
48.

Intracellular calcium movements during relaxation and recovery of superfast muscle fibers of the toadfish swimbladder.

Nelson FE, Hollingworth S, Rome LC, Baylor SM.

J Gen Physiol. 2014 May;143(5):605-20. doi: 10.1085/jgp.201411160. Epub 2014 Apr 14.

49.

A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial.

Zhang J, Burridge L, Baxter KA, Donald M, Foster MM, Hollingworth SA, Ware RS, Russell AW, Jackson CL.

Trials. 2013 Nov 12;14:382. doi: 10.1186/1745-6215-14-382.

50.

Quality of physical resources of health facilities in Indonesia: a panel study 1993-2007.

Diana A, Hollingworth SA, Marks GC.

Int J Qual Health Care. 2013 Oct;25(5):488-96. doi: 10.1093/intqhc/mzt057. Epub 2013 Aug 14.

PMID:
23946293

Supplemental Content

Loading ...
Support Center